Stock data
TuHURA Biosciences, Inc. (HURA)
TuHURA Biosciences, Inc. (HURA) reported revenue of US$0.00M and net income of -US$30.05M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | — | -US$30.05M | — |
| 2024 | US$0.00M | — | — | -US$21.68M | — |
| 2023 | US$0.00M | — | — | -US$29.32M | — |
| 2022 | — | — | — | -US$22.66M | — |
| 2021 | — | — | — | -US$38.30M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$9.22M | — |
| 2026-03-31 | US$0.00M | -US$7.54M | — |
| 2025-12-31 | — | -US$6.76M | — |
| 2025-09-30 | — | -US$7.10M | — |
| 2025-06-30 | — | -US$9.52M | — |
| 2025-03-31 | US$0.00M | -US$6.66M | — |
| 2024-12-31 | — | -US$6.00M | — |
| 2024-09-30 | — | -US$5.58M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.